week 3 of tirzepatide 4 maintenance with @morphwellnessmd is in the books!, #morphwellnessmd #morphyourself #morphmd #morphhealthandwellness , #WeightLossJourney #Tirzepatide #gethealthywithme Week 3 on Tirzepatide |

Zepbound, semaglutide GLP-1, and Wegovy have all been FDA-approved through studies to help non-diabetic patients with medical weight loss, as long as a patient has a BMI of 30 or greater, with considerations for patients with a BMI of 27 or higher that have other health conditions that could impede weight loss such as hypertension, high cholesterol and hormonal conditions like PCOS

PlexusDx compounded tirzepatide injection therapy is $289/mo month-to-month (or $249/mo on the 6-month plan) with a flat price structuremeaning your dose may need to increase over time, but your monthly cost remains consistent

The active ingredient is tirzepatide, which belongs to a class of drugs known as dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonists

Side effects were characteristic of the GLP-1 receptor agonist class profile and included serious gastrointestinal (1.4% vs 0% in placebo) and gallbladder (2.6% vs 1.2% in placebo) disorders